Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX)

Q: What does CUSIP 28036F105 represent in this 13F holders report?

CUSIP 28036F105 is the security identifier for EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q2 2023?

94 institutional investors reported EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 28036F105

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 105,503,387
Total 13F shares: 69,494,963
Share change: +3,039,291
Total reported value: $538,802,876
Put/Call ratio: 12%
Price per share: $7.75
Number of holders: 94
Value change: +$23,832,932
Number of buys: 52
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP 28036F105?
CUSIP 28036F105 identifies EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 28036F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	14%	14,567,176	$97,163,064	—	31 Mar 2023	13F
Novo Holdings A/S	3/4/5 13F	10%+ Owner · Company	5.8% from 13F	6,071,703	$95,781,722	—	14 Sep 2022	3/4/5 13F
FMR LLC	13F	Company	7.5%	7,940,542	$52,963,415	—	31 Mar 2023	13F
VIKING GLOBAL INVESTORS LP	13F	Company	4.7%	4,909,146	$32,744,004	—	31 Mar 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	3.7%	3,933,137	$26,234,024	—	31 Mar 2023	13F
EcoR1 Capital, LLC	13F	Company	3.3%	3,493,194	$23,299,604	—	31 Mar 2023	13F
Deep Track Capital, LP	13F	Company	2.9%	3,068,259	$20,465,288	—	31 Mar 2023	13F
Cormorant Asset Management, LP	13F	Company	2.8%	2,946,887	$19,656,000	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	2.7%	2,871,007	$19,149,616	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	2.6%	2,768,438	$18,465,482	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	1.9%	2,005,825	$13,378,853	—	31 Mar 2023	13F
New Leaf Venture Partners, L.L.C.	13F	Company	1.5%	1,553,661	$10,362,919	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.74%	775,487	$5,172,498	—	31 Mar 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.73%	769,799	$5,125,852	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.71%	754,139	$5,030,107	—	31 Mar 2023	13F
Opaleye Management Inc.	13F	Company	0.71%	750,000	$5,002,500	—	31 Mar 2023	13F
Granahan Investment Management, LLC	13F	Company	0.7%	733,664	$4,893,539	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	0.69%	733,239	$4,890,704	—	31 Mar 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	0.65%	682,461	$4,552,015	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.62%	658,623	$4,393,015	—	31 Mar 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.48%	509,062	$3,389,420	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	0.47%	500,000	$3,335,000	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.34%	360,093	$2,401,820	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.32%	340,906	$2,273,843	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.29%	306,084	$2,041,580	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.28%	294,311	$1,963,054	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	0.28%	298,000	$1,829,500	—	31 Mar 2023	13F
Tekla Capital Management LLC	13F	Company	0.18%	195,025	$1,300,817	—	31 Mar 2023	13F
ExodusPoint Capital Management, LP	13F	Company	0.13%	141,851	$946,000	—	31 Mar 2023	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.13%	132,968	$886,897	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.12%	123,880	$826,280	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.12%	122,570	$819,000	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.09%	97,824	$653,000	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.09%	96,800	$646,000	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.06%	64,273	$428,702	—	31 Mar 2023	13F
Parkman Healthcare Partners LLC	13F	Company	0.06%	62,283	$415,428	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.06%	58,331	$389,000	—	31 Mar 2023	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.05%	56,763	$378,610	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.05%	54,573	$364,002	—	31 Mar 2023	13F
Quantum Private Wealth, LLC	13F	Company	0.05%	48,719	$324,958	—	31 Mar 2023	13F
ALPS ADVISORS INC	13F	Company	0.04%	41,679	$277,999	—	31 Mar 2023	13F
CORNERCAP INVESTMENT COUNSEL INC	13F	Company	0.03%	31,904	$212,800	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.03%	31,653	$211,126	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.03%	31,380	$210,000	—	31 Mar 2023	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.03%	30,000	$200,000	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.03%	28,016	$186,867	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.03%	27,283	$181,977	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	25,800	$172,086	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.02%	24,736	$164,989	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	23,597	$157,392	—	31 Mar 2023	13F

Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) as of Q2 2023

As of 30 Jun 2023, Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 69,494,963 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, Novo Holdings A/S, VIKING GLOBAL INVESTORS LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), EcoR1 Capital, LLC, BlackRock Inc., Cormorant Asset Management, LP, Deep Track Capital, LP, and CITADEL ADVISORS LLC. This page lists 94 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.